David Hallal Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for David Hallal.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of David Hallal. David Hallal is CEO in ALEXION PHARMACEUTICALS INC ($ALXN) and Chief Operating Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP, Chief Commercial Officer in ALEXION PHARMACEUTICALS INC ($ALXN) and EVP. Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP Comm Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and Sr. VP Comm. Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP Commercial Ops, Americas in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP, Global Commerical Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and SVP. Global Commercial Ops in ALEXION PHARMACEUTICALS INC ($ALXN) and Director in Seer, Inc. ($SEER) and Director in Scholar Rock Holding Corp ($SRRK) and Chief Executive Officer in Allovir, Inc. ($ALVR) and Director in iTeos Therapeutics, Inc. ($ITOS).
Latest Insider Trading Transactions of David Hallal
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, ALXN, ALVR, ITOS, SRRK, SEER
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan 25 2021 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Option Exercise | A | 45.04 | 273,000 | 12,295,920 | 273,000 | |
| Jan 25 2021 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Grant | A | 0.00 | 147,000 | 0 | 2,230,666 | 2.1 M to 2.2 M (+7.05 %) |
| Dec 11 2020 | SEER | Seer, Inc. | Hallal David | Director | Option Exercise | A | 19.00 | 18,691 | 355,129 | 18,691 | |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Option Exercise | C | 0.00 | 1,100,000 | 0 | 0 | |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Option Exercise | C | 0.00 | 233,333 | 0 | 0 | |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Option Exercise | C | 0.00 | 20,000,000 | 0 | 0 | |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Buy | C | 0.00 | 738,153 | 0 | 738,153 | 0 to 738.2 K |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Buy | C | 0.00 | 156,577 | 0 | 1,120,965 | 964.4 K to 1.1 M (+16.24 %) |
| Aug 05 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Buy | C | 0.00 | 13,420,970 | 0 | 13,420,970 | 0 to 13.4 M |
| Jul 31 2020 | ALVR | Allovir, Inc. | Hallal David | Chief Executive Off ... | Option Exercise | A | 17.00 | 1,101,000 | 18,717,000 | 1,101,000 | |
| Jul 24 2020 | ITOS | iTeos Therapeutics ... | Hallal David | Director | Option Exercise | A | 19.00 | 16,608 | 315,552 | 0 | |
| Jun 18 2020 | SRRK | Scholar Rock Holdi ... | Hallal David | Director | Option Exercise | A | 17.65 | 7,000 | 123,550 | 7,000 | |
| Jun 18 2020 | SRRK | Scholar Rock Holdi ... | Hallal David | Director | Option Exercise | A | 17.65 | 13,000 | 229,450 | 13,000 | |
| Sep 20 2019 | SRRK | Scholar Rock Holdi ... | Hallal David | Director | Gift | G | 0.00 | 2,000 | 0 | 290,595 | 292.6 K to 290.6 K (-0.68 %) |
| May 23 2019 | SRRK | Scholar Rock Holdi ... | Hallal David | Director | Option Exercise | A | 21.21 | 10,158 | 215,451 | 10,158 | |
| Jun 26 2018 | SRRK | Scholar Rock Holdi ... | Hallal David | Director | Option Exercise | A | 21.62 | 20,316 | 439,232 | 20,316 | |
| Aug 10 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 137.14 | 332 | 45,530 | 189,266 | 189.6 K to 189.3 K (-0.18 %) |
| Apr 05 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 136.21 | 34 | 4,631 | 189,598 | 189.6 K to 189.6 K (-0.02 %) |
| Apr 05 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 135.87 | 1,380 | 187,501 | 189,632 | 191 K to 189.6 K (-0.72 %) |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Option Exercise | A | 140.16 | 131,000 | 18,360,960 | 131,000 | |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 141.45 | 14 | 1,980 | 191,012 | 191 K to 191 K (-0.01 %) |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 138.91 | 2,000 | 277,820 | 191,026 | 193 K to 191 K (-1.04 %) |
| Mar 01 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Grant | A | 0.00 | 20,000 | 0 | 193,026 | 173 K to 193 K (+11.56 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 138.02 | 3,492 | 481,966 | 173,026 | 176.5 K to 173 K (-1.98 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 139.18 | 117 | 16,284 | 176,518 | 176.6 K to 176.5 K (-0.07 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 138.02 | 337 | 46,513 | 176,635 | 177 K to 176.6 K (-0.19 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 140.49 | 1,490 | 209,330 | 176,972 | 178.5 K to 177 K (-0.83 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 141.40 | 3,710 | 524,594 | 178,462 | 182.2 K to 178.5 K (-2.04 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 142.35 | 712 | 101,353 | 182,172 | 182.9 K to 182.2 K (-0.39 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 143.45 | 300 | 43,035 | 182,884 | 183.2 K to 182.9 K (-0.16 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 144.45 | 400 | 57,780 | 183,184 | 183.6 K to 183.2 K (-0.22 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 145.01 | 110 | 15,951 | 183,584 | 183.7 K to 183.6 K (-0.06 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Grant | A | 0.00 | 41,136 | 0 | 183,694 | 142.6 K to 183.7 K (+28.86 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 145.05 | 10 | 1,451 | 142,558 | 142.6 K to 142.6 K (-0.01 %) |
| Feb 08 2016 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 143.81 | 619 | 89,018 | 142,568 | 143.2 K to 142.6 K (-0.43 %) |
| Aug 11 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 190.01 | 329 | 62,513 | 143,187 | 143.5 K to 143.2 K (-0.23 %) |
| Aug 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Sell | S | 196.52 | 612 | 120,270 | 143,516 | 144.1 K to 143.5 K (-0.42 %) |
| Apr 02 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Option Exercise | A | 173.30 | 49,275 | 8,539,358 | 49,275 | |
| Apr 02 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | CEO | Grant | A | 0.00 | 11,270 | 0 | 144,128 | 132.9 K to 144.1 K (+8.48 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | A | 180.37 | 7,626 | 1,375,502 | 7,626 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | A | 180.37 | 32,200 | 5,807,914 | 32,200 | |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 180.34 | 730 | 131,648 | 132,858 | 133.6 K to 132.9 K (-0.55 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 2,265 | 0 | 133,588 | 131.3 K to 133.6 K (+1.72 %) |
| Mar 03 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 7,290 | 0 | 131,323 | 124 K to 131.3 K (+5.88 %) |
| Feb 12 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 171.15 | 1,980 | 338,877 | 124,033 | 126 K to 124 K (-1.57 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 173.93 | 2,920 | 507,876 | 126,013 | 128.9 K to 126 K (-2.26 %) |
| Feb 09 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Grant | A | 0.00 | 11,690 | 0 | 128,933 | 117.2 K to 128.9 K (+9.97 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 174.38 | 608 | 106,023 | 117,243 | 117.9 K to 117.2 K (-0.52 %) |
| Feb 05 2015 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 174.02 | 765 | 133,125 | 117,851 | 118.6 K to 117.9 K (-0.64 %) |
| Dec 19 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 182.03 | 5,494 | 1,000,073 | 113,122 | 118.6 K to 113.1 K (-4.63 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | M | 17.65 | 14,336 | 253,030 | 0 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Option Exercise | M | 22.90 | 15,664 | 358,706 | 84,336 | |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 190.02 | 14,336 | 2,724,127 | 118,616 | 133 K to 118.6 K (-10.78 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Sell | S | 190.00 | 15,664 | 2,976,160 | 132,952 | 148.6 K to 133 K (-10.54 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Buy | M | 17.65 | 14,336 | 253,030 | 148,616 | 134.3 K to 148.6 K (+10.68 %) |
| Nov 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | Chief Operating Off ... | Buy | M | 22.90 | 15,664 | 358,706 | 134,280 | 118.6 K to 134.3 K (+13.21 %) |
| Aug 05 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 158.00 | 1,349 | 213,142 | 118,616 | 120 K to 118.6 K (-1.12 %) |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | A | 176.80 | 49,200 | 8,698,560 | 49,200 | |
| Mar 04 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Grant | A | 0.00 | 6,000 | 0 | 119,965 | 114 K to 120 K (+5.26 %) |
| Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 158.05 | 10 | 1,581 | 113,965 | 114 K to 114 K (-0.01 %) |
| Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 156.95 | 10 | 1,570 | 113,965 | 114 K to 114 K (-0.01 %) |
| Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 155.55 | 1,600 | 248,880 | 113,975 | 115.6 K to 114 K (-1.38 %) |
| Feb 10 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Grant | A | 0.00 | 9,745 | 0 | 115,575 | 105.8 K to 115.6 K (+9.21 %) |
| Feb 05 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 153.63 | 2,390 | 367,176 | 105,830 | 108.2 K to 105.8 K (-2.21 %) |
| Feb 05 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 157.14 | 729 | 114,555 | 108,220 | 108.9 K to 108.2 K (-0.67 %) |
| Jan 31 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 133.37 | 29 | 3,868 | 108,949 | 109 K to 108.9 K (-0.03 %) |
| Jan 31 2014 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 133.45 | 700 | 93,415 | 108,978 | 109.7 K to 109 K (-0.64 %) |
| Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.98 | 15,363 | 276,227 | 0 | |
| Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.98 | 7,295 | 131,128 | 0 | |
| Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 127.61 | 15,363 | 1,960,472 | 109,678 | 125 K to 109.7 K (-12.29 %) |
| Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Grant | A | 17.98 | 15,363 | 276,227 | 125,041 | 109.7 K to 125 K (+14.01 %) |
| Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 127.53 | 7,295 | 930,331 | 109,678 | 117 K to 109.7 K (-6.24 %) |
| Dec 20 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.98 | 7,295 | 131,164 | 116,973 | 109.7 K to 117 K (+6.65 %) |
| Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.98 | 14,637 | 263,173 | 15,363 | |
| Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.98 | 10,705 | 192,422 | 7,295 | |
| Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 127.63 | 14,637 | 1,868,120 | 109,678 | 124.3 K to 109.7 K (-11.77 %) |
| Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.98 | 14,637 | 263,173 | 124,315 | 109.7 K to 124.3 K (+13.35 %) |
| Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 127.63 | 10,705 | 1,366,279 | 109,678 | 120.4 K to 109.7 K (-8.89 %) |
| Dec 11 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.98 | 10,705 | 192,476 | 120,383 | 109.7 K to 120.4 K (+9.76 %) |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.98 | 18,000 | 323,550 | 18,000 | |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 123.77 | 7,963 | 985,581 | 88,178 | 96.1 K to 88.2 K (-8.28 %) |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 122.79 | 22,037 | 2,705,923 | 96,141 | 118.2 K to 96.1 K (-18.65 %) |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.98 | 30,000 | 539,400 | 118,178 | 88.2 K to 118.2 K (+34.02 %) |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 123.77 | 4,777 | 591,249 | 88,178 | 93 K to 88.2 K (-5.14 %) |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 122.79 | 13,223 | 1,623,652 | 92,955 | 106.2 K to 93 K (-12.45 %) |
| Oct 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.98 | 18,000 | 323,640 | 106,178 | 88.2 K to 106.2 K (+20.41 %) |
| Aug 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 116.87 | 730 | 85,315 | 88,178 | 88.9 K to 88.2 K (-0.82 %) |
| Aug 01 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 110.86 | 746 | 82,702 | 88,908 | 89.7 K to 88.9 K (-0.83 %) |
| Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.65 | 50,000 | 882,500 | 14,336 | |
| Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 120.00 | 50,000 | 6,000,000 | 89,654 | 139.7 K to 89.7 K (-35.80 %) |
| Jul 16 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.65 | 50,000 | 882,500 | 139,654 | 89.7 K to 139.7 K (+55.77 %) |
| Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 17.65 | 5,664 | 99,970 | 0 | |
| Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 11.92 | 5,692 | 67,849 | 0 | |
| Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 10.29 | 3,128 | 32,187 | 0 | |
| Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | M | 8.16 | 524 | 4,276 | 0 | |
| Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 17.65 | 5,664 | 99,970 | 89,654 | 84 K to 89.7 K (+6.74 %) |
| Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 11.92 | 5,692 | 67,849 | 83,990 | 78.3 K to 84 K (+7.27 %) |
| Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 10.29 | 3,128 | 32,187 | 78,298 | 75.2 K to 78.3 K (+4.16 %) |
| Jun 07 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Buy | M | 8.16 | 524 | 4,276 | 75,170 | 74.6 K to 75.2 K (+0.70 %) |
| Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Option Exercise | A | 93.83 | 73,000 | 6,849,590 | 73,000 | |
| Feb 08 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Grant | A | 0.00 | 5,400 | 0 | 74,646 | 69.2 K to 74.6 K (+7.80 %) |
| Feb 06 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 96.74 | 985 | 95,289 | 69,246 | 70.2 K to 69.2 K (-1.40 %) |
| Feb 06 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP, Chief Commerci ... | Sell | S | 95.68 | 1,100 | 105,248 | 70,231 | 71.3 K to 70.2 K (-1.54 %) |
| Jan 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP. Global Commerc ... | Sell | S | 94.32 | 512 | 48,292 | 71,331 | 71.8 K to 71.3 K (-0.71 %) |
| Jan 30 2013 | ALXN | ALEXION PHARMACEUT ... | Hallal David | EVP. Global Commerc ... | Sell | S | 94.50 | 632 | 59,724 | 71,843 | 72.5 K to 71.8 K (-0.87 %) |
| Oct 26 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Option Exercise | M | 8.16 | 10,500 | 85,680 | 524 | |
| Oct 26 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Buy | M | 8.16 | 10,500 | 85,680 | 72,475 | 62 K to 72.5 K (+16.94 %) |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Option Exercise | M | 17.65 | 50,000 | 882,500 | 64,336 | |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Sell | S | 104.99 | 680 | 71,393 | 61,975 | 62.7 K to 62 K (-1.09 %) |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Sell | S | 106.14 | 555 | 58,908 | 62,655 | 63.2 K to 62.7 K (-0.88 %) |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Sell | S | 107.74 | 50,000 | 5,387,000 | 63,210 | 113.2 K to 63.2 K (-44.17 %) |
| Jul 31 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Buy | M | 17.65 | 50,000 | 882,500 | 113,210 | 63.2 K to 113.2 K (+79.10 %) |
| Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 11.92 | 14,308 | 170,551 | 0 | |
| Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 93.67 | 14,308 | 1,340,230 | 63,210 | 77.5 K to 63.2 K (-18.46 %) |
| Jun 19 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 11.92 | 14,308 | 170,551 | 77,518 | 63.2 K to 77.5 K (+22.64 %) |
| May 11 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 8.16 | 10,000 | 81,600 | 84,710 | |
| May 11 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 8.16 | 10,000 | 81,600 | 63,210 | 53.2 K to 63.2 K (+18.79 %) |
| Feb 24 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 11.92 | 40,000 | 476,800 | 14,308 | |
| Feb 24 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 85.50 | 40,000 | 3,420,000 | 53,210 | 93.2 K to 53.2 K (-42.91 %) |
| Feb 24 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 11.92 | 40,000 | 476,800 | 93,210 | 53.2 K to 93.2 K (+75.17 %) |
| Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 78.88 | 77,000 | 6,073,760 | 77,000 | |
| Feb 06 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 0.00 | 10,000 | 0 | 53,210 | 43.2 K to 53.2 K (+23.14 %) |
| Jan 30 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 74.51 | 1,896 | 141,271 | 39,749 | 41.6 K to 39.7 K (-4.55 %) |
| Jan 30 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 74.41 | 554 | 41,223 | 41,645 | 42.2 K to 41.6 K (-1.31 %) |
| Jan 11 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 75.00 | 536 | 40,200 | 42,199 | 42.7 K to 42.2 K (-1.25 %) |
| Jan 04 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 8.16 | 3,000 | 24,480 | 21,024 | |
| Jan 04 2012 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 8.16 | 3,000 | 24,480 | 42,735 | 39.7 K to 42.7 K (+7.55 %) |
| Nov 30 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 11.92 | 20,000 | 238,400 | 54,308 | |
| Nov 30 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 66.59 | 20,000 | 1,331,800 | 39,735 | 59.7 K to 39.7 K (-33.48 %) |
| Nov 30 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 11.92 | 20,000 | 238,400 | 59,735 | 39.7 K to 59.7 K (+50.33 %) |
| Aug 09 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 8.16 | 5,000 | 40,800 | 24,024 | |
| Aug 09 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | M | 8.16 | 5,000 | 40,800 | 29,024 | |
| Aug 09 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 8.16 | 5,000 | 40,800 | 39,735 | 34.7 K to 39.7 K (+14.39 %) |
| Aug 09 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 8.16 | 5,000 | 40,800 | 34,735 | 29.7 K to 34.7 K (+16.82 %) |
| Jul 28 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Option Exercise | M | 10.29 | 36,872 | 379,413 | 0 | |
| Jul 28 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Sell | S | 57.33 | 36,872 | 2,113,872 | 29,735 | 66.6 K to 29.7 K (-55.36 %) |
| Jul 28 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Buy | M | 10.29 | 36,872 | 379,413 | 66,607 | 29.7 K to 66.6 K (+124.00 %) |
| Jul 28 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Sell | S | 57.27 | 555 | 31,785 | 29,735 | 30.3 K to 29.7 K (-1.83 %) |
| Jul 12 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 50.00 | 501 | 25,050 | 30,290 | 30.8 K to 30.3 K (-1.63 %) |
| Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | S | 20.58 | 4,900 | 100,842 | 18,436 | |
| Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Option Exercise | S | 20.58 | 100 | 2,058 | 23,336 | |
| Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 99.21 | 4,900 | 486,129 | 15,646 | 20.5 K to 15.6 K (-23.85 %) |
| Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 20.58 | 4,900 | 100,842 | 20,546 | 15.6 K to 20.5 K (+31.32 %) |
| Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 100.00 | 100 | 10,000 | 15,646 | 15.7 K to 15.6 K (-0.64 %) |
| Mar 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Buy | M | 20.58 | 100 | 2,058 | 15,746 | 15.6 K to 15.7 K (+0.64 %) |
| Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Option Exercise | A | 85.31 | 50,000 | 4,265,500 | 50,000 | |
| Feb 04 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP. Global Commerc ... | Grant | A | 0.00 | 6,000 | 0 | 15,646 | 9.6 K to 15.6 K (+62.20 %) |
| Jan 28 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commeri ... | Sell | S | 84.70 | 1,110 | 94,017 | 9,646 | 10.8 K to 9.6 K (-10.32 %) |
| Jan 18 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 82.66 | 245 | 20,252 | 10,756 | 11 K to 10.8 K (-2.23 %) |
| Jan 12 2011 | ALXN | ALEXION PHARMACEUT ... | Hallal David | SVP, Global Commerc ... | Sell | S | 81.27 | 269 | 21,862 | 11,001 | 11.3 K to 11 K (-2.39 %) |